Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting Gordon R DeFoe, Cathy S Ross, MS, Elaine M Olmstead, BS, Stephen D Surgenor, MD, Mary P Fillinger, MD, Robert C Groom, Richard J Forest, John W Pieroni, Craig S Warren, Mary E Bogosian, RN, Charles F Krumholz, Cantwell Clark, MD, Robert A Clough, MD, Paul W Weldner, MD, Stephen J Lahey, MD, Bruce J Leavitt, MD, Charles A.S Marrin, MB, BS, David C Charlesworth, MD, Peter Marshall, MD, Gerald T O’Connor, PhD The Annals of Thoracic Surgery Volume 71, Issue 3, Pages 769-776 (March 2001) DOI: 10.1016/S0003-4975(00)02393-6
Fig 1 Distribution of values of lowest hematocrit measured during cardiopulmonary bypass. The Annals of Thoracic Surgery 2001 71, 769-776DOI: (10.1016/S0003-4975(00)02393-6)
Fig 2 (A) Adjusted mortality rates by lowest hematocrit for all patients. Rates are adjusted for the following variables: age, sex, body surface area, comorbidity score, prior coronary artery bypass graft, ejection fraction, left ventricular end-diastolic pressure (LVEDP), and priority at surgery. (B) Adjusted mortality rates by lowest hematocrit by sex. The Annals of Thoracic Surgery 2001 71, 769-776DOI: (10.1016/S0003-4975(00)02393-6)
Fig 3 Lowest hematocrit (Hct) during cardiopulmonary bypass by sex, body surface area (BSA) category, and preop hematocrit. The Annals of Thoracic Surgery 2001 71, 769-776DOI: (10.1016/S0003-4975(00)02393-6)